168 related articles for article (PubMed ID: 36726200)
81. Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling.
Koskinen C; Persson E; Baldock P; Stenberg Å; Boström I; Matozaki T; Oldenborg PA; Lundberg P
J Biol Chem; 2013 Oct; 288(41):29333-44. PubMed ID: 23990469
[TBL] [Abstract][Full Text] [Related]
82. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
83. Autophagy in osteoblasts is involved in mineralization and bone homeostasis.
Nollet M; Santucci-Darmanin S; Breuil V; Al-Sahlanee R; Cros C; Topi M; Momier D; Samson M; Pagnotta S; Cailleteau L; Battaglia S; Farlay D; Dacquin R; Barois N; Jurdic P; Boivin G; Heymann D; Lafont F; Lu SS; Dempster DW; Carle GF; Pierrefite-Carle V
Autophagy; 2014; 10(11):1965-77. PubMed ID: 25484092
[TBL] [Abstract][Full Text] [Related]
84. Hdac3 regulates bone modeling by suppressing osteoclast responsiveness to RANKL.
Molstad DHH; Mattson AM; Begun DL; Westendorf JJ; Bradley EW
J Biol Chem; 2020 Dec; 295(51):17713-17723. PubMed ID: 33454009
[TBL] [Abstract][Full Text] [Related]
85. Osteoblasts of calvaria induce higher numbers of osteoclasts than osteoblasts from long bone.
Wan Q; Schoenmaker T; Jansen ID; Bian Z; de Vries TJ; Everts V
Bone; 2016 May; 86():10-21. PubMed ID: 26921824
[TBL] [Abstract][Full Text] [Related]
86. Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells.
Schulze J; Bickert T; Beil FT; Zaiss MM; Albers J; Wintges K; Streichert T; Klaetschke K; Keller J; Hissnauer TN; Spiro AS; Gessner A; Schett G; Amling M; McKenzie AN; Horst AK; Schinke T
J Bone Miner Res; 2011 Apr; 26(4):704-17. PubMed ID: 20939024
[TBL] [Abstract][Full Text] [Related]
87. Age-related skeletal dynamics and decrease in bone strength in DNA repair deficient male trichothiodystrophy mice.
Nicolaije C; Diderich KE; Botter SM; Priemel M; Waarsing JH; Day JS; Brandt RM; Schilling AF; Weinans H; Van der Eerden BC; van der Horst GT; Hoeijmakers JH; van Leeuwen JP
PLoS One; 2012; 7(4):e35246. PubMed ID: 22506075
[TBL] [Abstract][Full Text] [Related]
88. Ablation of Stabilin-1 Enhances Bone-Resorbing Activity in Osteoclasts In Vitro.
Kim SY; Lee EH; Park SY; Choi H; Koh JT; Park EK; Kim IS; Kim JE
Calcif Tissue Int; 2019 Aug; 105(2):205-214. PubMed ID: 31025051
[TBL] [Abstract][Full Text] [Related]
89. The ATF3-OPG Axis Contributes to Bone Formation by Regulating the Differentiation of Osteoclasts, Osteoblasts, and Adipocytes.
Kim JH; Kim K; Kim I; Seong S; Koh JT; Kim N
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408860
[TBL] [Abstract][Full Text] [Related]
90. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J
Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950
[TBL] [Abstract][Full Text] [Related]
91. DJ-1 controls bone homeostasis through the regulation of osteoclast differentiation.
Kim HS; Nam ST; Mun SH; Lee SK; Kim HW; Park YH; Kim B; Won KJ; Kim HR; Park YM; Kim HS; Beaven MA; Kim YM; Choi WS
Nat Commun; 2017 Nov; 8(1):1519. PubMed ID: 29142196
[TBL] [Abstract][Full Text] [Related]
92. Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.
Liu FL; Chen CL; Lai CC; Lee CC; Chang DM
Phytomedicine; 2020 Apr; 69():153195. PubMed ID: 32200293
[TBL] [Abstract][Full Text] [Related]
93. MAGED1 is a negative regulator of bone remodeling in mice.
Liu M; Xu L; Ma X; Xu J; Wang J; Xian M; Zhou X; Wang M; Wang F; Qin A; Pan Q; Wen C
Am J Pathol; 2015 Oct; 185(10):2653-67. PubMed ID: 26272363
[TBL] [Abstract][Full Text] [Related]
94. High-fat diet causes bone loss in young mice by promoting osteoclastogenesis through alteration of the bone marrow environment.
Shu L; Beier E; Sheu T; Zhang H; Zuscik MJ; Puzas EJ; Boyce BF; Mooney RA; Xing L
Calcif Tissue Int; 2015 Apr; 96(4):313-23. PubMed ID: 25673503
[TBL] [Abstract][Full Text] [Related]
95. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065
[TBL] [Abstract][Full Text] [Related]
96. RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss.
Hu Y; Li X; Zhi X; Cong W; Huang B; Chen H; Wang Y; Li Y; Wang L; Fang C; Guo J; Liu Y; Cui J; Cao L; Weng W; Zhou Q; Wang S; Chen X; Su J
EMBO Rep; 2021 Jul; 22(7):e52481. PubMed ID: 34121311
[TBL] [Abstract][Full Text] [Related]
97. Mature osteoclast-derived apoptotic bodies promote osteogenic differentiation via RANKL-mediated reverse signaling.
Ma Q; Liang M; Wu Y; Ding N; Duan L; Yu T; Bai Y; Kang F; Dong S; Xu J; Dou C
J Biol Chem; 2019 Jul; 294(29):11240-11247. PubMed ID: 31167789
[TBL] [Abstract][Full Text] [Related]
98. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.
Lee JW; Iwahashi A; Hasegawa S; Yonezawa T; Jeon WB; Cha BY; Nagai K; Woo JT
J Nat Med; 2012 Jan; 66(1):8-16. PubMed ID: 21656335
[TBL] [Abstract][Full Text] [Related]
99. The Multifarious Functions of Leukotrienes in Bone Metabolism.
Amadeu de Oliveira F; Tokuhara CK; Veeriah V; Domezi JP; Santesso MR; Cestari TM; Ventura TMO; Matos AA; Dionísio T; Ferreira MR; Ortiz RC; Duarte MAH; Buzalaf MAR; Ponce JB; Sorgi CA; Faccioli LH; Buzalaf CP; de Oliveira RC
J Bone Miner Res; 2023 Aug; 38(8):1135-1153. PubMed ID: 37314430
[TBL] [Abstract][Full Text] [Related]
100. Genetic Deficiency of the Long Pentraxin 3 Affects Osteogenesis and Osteoclastogenesis in Homeostatic and Inflammatory Conditions.
Granata V; Strina D; Schiavone ML; Bottazzi B; Mantovani A; Inforzato A; Sobacchi C
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
